Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia

Journal of Neuroscience

Volumn 22, Issue 7, 2002, Pages 2718-2729

  Middleton, Frank A ^a   Mirnics, Karoly ^a   Pierri, Joseph N ^a   Lewis, David A ^a   Levitt, Pat ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aspartate; Citrate; Haloperidol; Malate; Microarray; Mitochondria; Neuroleptic; Ornithine; Polyamine; Prefrontal; Transcarboxylic acid; Ubiquitin

Indexed keywords

ALANINE; ASPARTIC ACID; BENZATROPINE MESILATE; CARBOXYLIC ACID; HALOPERIDOL DECANOATE; MALIC ACID; NEUROLEPTIC AGENT; ORNITHINE; POLYAMINE; UBIQUITIN; HALOPERIDOL; MALIC ACID DERIVATIVE;

ADULT; AGED; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG BLOOD LEVEL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC CODE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MITOCHONDRION; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; DRUG EFFECT; GENE EXPRESSION; MACACA; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADULT; AGED; ALANINE; ANIMALS; ANTIPSYCHOTIC AGENTS; ASPARTIC ACID; BIOGENIC POLYAMINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HALOPERIDOL; HUMANS; IN SITU HYBRIDIZATION; LOGISTIC MODELS; MACACA FASCICULARIS; MALATES; MALE; MIDDLE AGED; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORNITHINE; PREFRONTAL CORTEX; SCHIZOPHRENIA; UBIQUITIN;

EID: 0036550998     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-07-02718.2002     Document Type: Article

References (61)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (1989) Molecular biology of the cell, Ed 2. New York: Garland.
2. Andreasen NC, Rezai K, Alliger R, Swayze II VW, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943-958.
3. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH (2001) Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 49:510-522.
4. Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC (2001) Reduced NAA in the thalamus, altered membrane, glial metabolism in schizophrenic patients detected by 1H-MRS, tissue segmentation. Schizophr Res 52:87-99.
5. Berman KF, Zec RF, Weinberger DR (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention and mental effort. Arch Gen Psychiatry 43:126-135.
6. Berman KF, Torrey F, Daniel DG, Weinberger DR (1992) Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 49:927-934.
7. Bernstein HG, Grecksch G, Becker A, Hollt V, Bogerts B (1999) Cellular changes in rat brain areas associated with neonatal hippocampal damage. NeuroReport 10:2307-2311.
8. Bernstein HG, Muller M (1999) The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems. Prog Neurobiol 57:485-505.
9. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR (1998) Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 43:641-648.
10. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR (2000) Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 157:26-33.
11. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney W (1992) Frontrostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935-942.
12. Burlina A, Visentin B (1965) Ricerche di enzimopatologia negli stati schizofrenici. I. La malico-deidrogenasi del siero. Riv Anat Patol Oncol 27:380-386.
13. Callicott JH, Ramsey NF, Tallent K, Bertolino A, Knable MB, Coppola R, Goldberg T, van Gelderen P, Mattay VS, Frank JA, Moonen CT, Weinberger DR (1998) Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18:186-196.
14. Campbell DB, North JB, Hess E (1999) Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp Neurol 160:268-278.
15. Cecil KM, Lenkinski RE, Gur RE, Gur RC (1999) Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20:131-140.
16. Darnell J, Lodish H, Baltimore D (1990) Molecular cell biology, Ed 2. Oxford: Scientific American Books.
17. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW (1997) Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 154:688-690.
18. DiAntonio A, Haghighi AP, Portman SL, Lee JD, Amaranto AM, Goodman CS (2001) Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412:449-452.
19. Fenton WS, Hibbeln J, Knable M (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47:8-21.
20. Flayeh KA (1988) Permidine oxidase activity in serum of normal and schizophrenic subjects. Clin Chem 34:401-403.
21. Gilad GM, Gilad VH, Casanova MF, Casero RA (1995) Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol Psychiatry 38:227-234.
22. Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 54:943-952.
23. Glantz LA, Lewis DA (2000) Decreased dendritic spine density of prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57:65-73.
24. Goldman-Rakic PS (1991) Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In: Psychopathology and the brain (Carroll BJ, Barrett JE, eds), pp 1-23. New York: Raven.
25. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593-624.
26. Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi M, Chain DG, Martin KC, Kandel ER, Schwartz JH (1997) Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89:115-126.
27. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for " hypofrontality." Mol Psychiatry 4:39-45.
28. Kashiwagi K, Pahk AJ, Masuko T, Igarashi K, Williams K (1997) Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol Pharmacol 52:701-713.
29. Kauppinen RA, Alhonen LI (1995) Transgenic animals as models in the study of the neurobiological role of polyamines. Prog Neurobiol 47:545-563.
30. Keshavan MS, Stanley JA, Pettegrew JW (2000) Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part II. Biol Psychiatry 48:369-380.
31. Kim RY, Gasser R, Wistow GJ (1992) mu-Crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci USA 89:9292-9296.
32. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75.
33. Marchbanks RM, Mulcrone J, Whatley SA (1995) Aspects of oxidative metabolism in schizophrenia. Br J Psychiatry 167:293-298.
34. Mathews CK, van Holde KE (1989) Biochemistry. Raven City, CA: Cummings.
35. Maurer I, Zierz S, Moller H (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48:125-136.
36. Mirnics K, Middleton FA, Marquez AM, Lewis DA, Levitt P (2000) Molecular characterization of schizophrenia revealed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
37. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001a) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6:293-301.
38. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001b) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24:479-486.
39. Mulcrone J, Whatley SA, Ferrier IN, Marchbanks RM (1995) A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophr Res 14:203-213.
40. 14C]2-deoxyglucose labeling of synaptic activity in the central auditory system. J Comp Neurol 245:553-565.
41. Park S, Holzman PS (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982.
42. Perrone-Bizzozero N, Sower A, Bird E, Benowitz L, Ivins K, Neve R (1996) Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 93:14182-14187.
43. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48:563-568.
44. Pierri JN, Chaudry BS, Woo TUW, Lewis DA (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 156:1709-1719.
45. Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21:372-379.
46. Prince JA, Yassin MS, Oreland L (1997a) Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther 280:261-267.
47. Prince JA, Yassin MS, Oreland L (1997b) Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine. Neuropharmacology 36:1665-1678.
48. Ramchand CN, Das I, Gliddon A, Hirsch SR (1994) Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res 13:227-234.
49. Selemon LD, Goldman-Rakic PS (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45:17-25.
50. Siegel G, Agranoff B, Albers RW, Molinoff P (1989) Basic neurochemistry, Ed 4. New York: Raven.
51. Sokoloff L (1977) Relation between physiological function and energy metabolism in the central nervous system. J Neurochem 29:13-26.
52. Stanley JA, Pettegrew JW, Keshavan MS (2000) Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part I. Biol Psychiatry 48:357-368.
53. Svinarev VI (1987) Serum spermidine levels of schizophrenic patients. Zh Nevropatol Psikhiatr 87:732-734.
54. Thaker GK, Carpenter WT (2001) Advances in schizophrenia. Nat Med 7:667-671.
55. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood III WH, Donovan DM, Webster M, Freed WJ, Becker KG (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55:641-650.
56. Volk DV, Austin MC, Pierri JN, Sampson RA, Lewis DA (2000) Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in schizophrenia. Arch Gen Psychiatry 57:237-245.
57. Weinberger DR, Berman KF, Zec RF (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-124.
58. Whatley SA, Curti D, Marchbanks RM (1996) Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res 21:995-1004.
59. Williams K (1997) Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9:1-13.
60. Williams K, Romano C, Dichter MA, Molinoff PB (1991) Modulation of the NMDA receptor by polyamines. Life Sci 48:469-498.
61. Yao JK, Leonard S, Reddy RD (2000) Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 42:7-17.